Literature DB >> 3119554

Antitrichomonal activity of alpha-difluoromethylornithine.

A F Bremner1, G H Coombs, M J North.   

Abstract

alpha-Difluoromethylornithine, an inhibitor of polyamine biosynthesis, affected the pathogenicity of Trichomonas vaginalis in two model systems. Firstly, it blocked the cytotoxic effect of the parasite towards mammalian cells in culture: at a concentration of 1 mM it prevented the death of mouse myeloma cells in mixed culture with trichomonads. Secondly, when administered orally to mice (multiple doses of 750 mg/kg body wt), the drug delayed the development of subcutaneous abscesses due to T. vaginalis infection. The same drug dose did not cure intravaginal infections by the parasite. The implications of these findings with respect to the value of the model systems used and the potential of DFMO as an antitrichomonal drug are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119554     DOI: 10.1093/jac/20.3.405

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Trifluoromethionine, a prodrug designed against methionine gamma-lyase-containing pathogens, has efficacy in vitro and in vivo against Trichomonas vaginalis.

Authors:  G H Coombs; J C Mottram
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Clinical and microbiological aspects of Trichomonas vaginalis.

Authors:  D Petrin; K Delgaty; R Bhatt; G Garber
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

3.  Inhibition of polyamine synthesis arrests trichomonad growth and induces destruction of hydrogenosomes.

Authors:  I A Reis; M P Martinez; N Yarlett; P J Johnson; F C Silva-Filho; M A Vannier-Santos
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

4.  Trichomonas vaginalis polyamine metabolism is linked to host cell adherence and cytotoxicity.

Authors:  Ana F Garcia; M Benchimol; J F Alderete
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.